Tu1536 RISK OF CANCER RECURRENCE AND OVERALL SURVIVAL OF PATIENTS WITH CHRONIC HEPATITIS B AND/OR HEPATIC STEATOSIS AFTER SURGICAL RESECTION FOR HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Risultati per: Terapia sistemica del carcinoma epatocellulare
Questo è quello che abbiamo trovato per te
Tu1549 INTRATUMORAL SALMONELLA ABUNDANCE IN HEPATOCELLULAR CARCINOMA IS ASSOCIATED WITH INCREASED DENDRITIC CELL INFILTRATE AND IMPROVED SURVIVAL OUTCOMES
Leggi →
Maggio 2024
Tu1553 RACIAL AND SOCIOECONOMIC DIFFERENCES IN INTENSITY OF ENDOF-LIFE CARE AMONG TERMINAL HEPATOCELLULAR CARCINOMA PATIENTS
Leggi →
Maggio 2024
Tu1552 RIBOSOMAL PROTEINS RPS8 AND RPLP0 PROMOTE HEPATOCELLULAR CARCINOMA METASTASIS
Leggi →
Maggio 2024
Tu1540 SOCIODEMOGRAPHIC FACTORS EXACERBATE EXISTING DISPARITIES IN TUMOR STAGE AT DIAGNOSIS AMONG ETHNIC MINORITIES WITH HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Tu1541 UPREGULATION OF ANDROGEN RECEPTOR TRANSCRIPTIONAL ACTIVITY IN A-FETOPROTEIN-NEGATIVE HEPATOCELLULAR CARCINOMA PROMOTES ARACHIDONIC ACID METABOLISM AND FORMATION OF ANGIOGENESIS MICROENVIRONMENT
Leggi →
Maggio 2024
Tu1548 BARRIERS TO HEPATOCELLULAR CARCINOMA SCREENING IN PATIENTS WITH MEDICAID INSURANCE: A PATIENT SURVEY
Leggi →
Maggio 2024
Tu1544 CLINICAL BENEFITS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE IN A CONTEMPORARY COHORT OF AT-RISK PATIENTS
Leggi →
Maggio 2024
Tu1545 CLINICAL SIGNIFICANCE OF SERUM C-REACTIVE PROTEIN LEVELS FOR PREDICTING LENVATINIB-TREATED UNRESECTABLE HEPATOCELLULAR CARCINOMA: A MULTI-INSTITUTIONAL STUDY IN JAPAN
Leggi →
Maggio 2024
Su1571 METFORMIN-MEDIATED ENHANCEMENT OF HEPATOCELLULAR CARCINOMA PROGNOSIS THROUGH IL33: INSIGHTS FROM TRANSCRIPTOME ANALYSIS
Leggi →
Maggio 2024
Tu1558 MODIFIED MELD 3.0 SARCOPENIA SCORES IMPROVE PREDICTIVE ACCURACY FOR OVERALL SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING LOCOREGIONAL THERAPY.
Leggi →
Maggio 2024
Mo1248 DEVELOPMENT OF PANEL OF THREE-DIMENSIONAL BIOMARKERS TO IDENTIFY GASTRIC CARCINOMA AND PRECANCEROUS LESIONS OF THE STOMACH – AN ANALYTICAL CROSS-SECTIONAL STUDY
Leggi →
Maggio 2024
Tu1555 IMMUNOTHERAPY VERSUS LENVATINIB IN ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTER, NATIONWIDE PROPENSITY SCORE MATCHING ANALYSIS
Leggi →
Maggio 2024
Tu1534 MULTICENTER COMPARISON OF ABBREVIATED MRI VERSUS ULTRASOUND FOR DETECTING EARLY-STAGE HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS
Leggi →
Maggio 2024
Tu1571 ANALYZING THE TRENDS AND GENDER DISPARITIES IN HEPATITIS CRELATED HEPATOCELLULAR CARCINOMA MORTALITY RATES IN WORLD BANK REGIONS USING THE GLOBAL BURDEN OF DISEASE DATABASE FROM 1999 TO 2019
Leggi →
Maggio 2024
Tu1550 COMBINATION IRREVERSIBLE ELECTROPORATION AND ANTI-PD1 THERAPY REVERSES MDSC INDUCED IMMUNE-SUPPRESSIVE MICROENVIRONMENT IN HEPATOCELLULAR CARCINOMA.
Leggi →
Maggio 2024
